Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
FENC | US
0.04
0.72%
Healthcare
Biotechnology
30/06/2024
30/08/2024
5.57
5.55
5.60
5.38
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park North Carolina.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
40.7%1 month
64.0%3 months
50.6%6 months
59.6%79.57
28.90
57.93
-21.93
0.47
21.06
2.84
-
-13.01M
158.69M
158.69M
-
-69.39
-
118.40
-1.01K
22.48
10.17
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.89
Range1M
1.58
Range3M
2.31
Rel. volume
1.26
Price X volume
663.93K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Outlook Therapeutics Inc | OTLK | Biotechnology | 7.35 | 173.87M | 0.68% | n/a | -39.11% |
Shattuck Labs Inc | STTK | Biotechnology | 3.59 | 171.34M | 2.87% | n/a | 3.45% |
Alpha Tau Medical Ltd. Class A Ordinary Shares | DRTS | Biotechnology | 2.45 | 171.31M | 8.41% | n/a | 0.00% |
MediWound Ltd | MDWD | Biotechnology | 18.39 | 170.77M | 0.88% | n/a | 0.00% |
DiaMedica Therapeutics Inc | DMAC | Biotechnology | 3.93 | 168.00M | -0.25% | n/a | 0.00% |
ProQR Therapeutics N.V | PRQR | Biotechnology | 2.02 | 164.99M | 1.51% | n/a | 53.73% |
Acumen Pharmaceuticals Inc. Common Stock | ABOS | Biotechnology | 2.74 | 164.62M | -2.49% | n/a | 11.57% |
Coherus BioSciences Inc | CHRS | Biotechnology | 1.39 | 160.14M | -2.11% | n/a | -354.71% |
Ventyx Biosciences Inc. Common Stock | VTYX | Biotechnology | 2.23 | 157.59M | 1.36% | n/a | 4.01% |
Achieve Life Sciences Inc | ACHV | Biotechnology | 4.39 | 150.76M | -0.90% | n/a | 41.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.7 | 152.52M | -0.37% | 8.42 | 71.47% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14.72 | 92.17M | -2.06% | 14.72 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.38 | 76.89M | 5.34% | n/a | 268.43% |
Emmis Communications Corporation | EMMS | Broadcasting - Radio | 4.7 | 57.98M | -1.05% | n/a | 54.59% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 0.6131 | 18.67M | -4.20% | n/a | 204.46% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 21.06 | 0.97 | Expensive |
Ent. to Revenue | 2.84 | 3,681.29 | Cheaper |
PE Ratio | 79.57 | 39.83 | Expensive |
Price to Book | 57.93 | 14.54 | Expensive |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 50.59 | 76.13 | Lower Risk |
Debt to Equity | -21.93 | -2.05 | Cheaper |
Debt to Assets | 0.47 | 0.25 | Expensive |
Market Cap | 158.69M | 4.04B | Emerging |